Literature DB >> 9711343

Failure of albendazole as an alternative treatment of cutaneous leishmaniasis in the hamster model.

B Travi1, Y Osorio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9711343     DOI： 10.1590/s0074-02761998000400018

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  4 in total

1.  Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations.

Authors:  Christian Bustamante; Rodrigo Ochoa; Claudia Asela; Carlos Muskus
Journal:  J Comput Aided Mol Des       Date:  2019-10-14       Impact factor: 3.686

2.  Cutaneous leishmaniasis in the dorsal skin of hamsters: a useful model for the screening of antileishmanial drugs.

Authors:  Sara M Robledo; Lina M Carrillo; Alejandro Daza; Adriana M Restrepo; Diana L Muñoz; Jairo Tobón; Javier D Murillo; Anderson López; Carolina Ríos; Carol V Mesa; Yulieth A Upegui; Alejandro Valencia-Tobón; Karina Mondragón-Shem; Berardo Rodríguez; Iván D Vélez
Journal:  J Vis Exp       Date:  2012-04-21       Impact factor: 1.355

3.  In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis.

Authors:  Viviana M Taylor; David L Cedeño; Diana L Muñoz; Marjorie A Jones; Timothy D Lash; Alexandra M Young; Manuel H Constantino; Nicholas Esposito; Iván D Vélez; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

4.  Applied Machine Learning Toward Drug Discovery Enhancement: Leishmaniases as a Case Study.

Authors:  Emna Harigua-Souiai; Rafeh Oualha; Oussama Souiai; Ines Abdeljaoued-Tej; Ikram Guizani
Journal:  Bioinform Biol Insights       Date:  2022-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.